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Abstract
Background: Intrauterine infection is the main contributor to maternal-infantile transmission of HBV. This is a
retrospective study of 158 HBsAg-positive pregnant women who delivered children from Jan 1st, 2004 to Dec.31th,
2006 in Wuhan City, China. We investigated the measures taken to prevent maternal-infantile transmission of
hepatitis B virus and the infection status of children.
Methods: HBsAg-positive pregnant women were selected by a random sampling method when they accepted
prenatal care in district-level Maternal and Child Health Hospitals. On a voluntary basis, these women completed
questionnaires by face-to-face or phone interviews. The collected data were used to evaluate the immunization
programs that pregnant women had received for preventing hepatitis B maternal-infantile transmission.
Results: Among the 158 women, 143(90.5%) received Hepatitis B immune globulin during pregnancy, and 86.0%
of their children were given Hepatitis B immune globulin and Hepatitis B vaccine. The rate of cesarean section was
82.3%, and 28.5% of these were aimed at preventing HBV infection. The rate of bottle feeding was 51.9%, and
89.0% of bottle feeding cases were for the purpose of preventing HBV infection. There were 71 cases of
participants who were HBeAg-positive. Compared with the HBsAg+ HBeAg- group (only HBsAg-positive), the
HBsAg + HBeAg+ group (HBsAg-positive and HBeAg-positive) had significantly higher rates of the caesarean
section and bottle feeding resulting from hepatitis B (P < 0.05). Five cases were HBsAg-positive by Umbilical Cord
Blood detection. The intrauterine infection rate of newborns was 6.7%. The chronic HBV rate of children was 4.0%.
Conclusion: Most HBsAg positive pregnant women have a growing awareness of maternal-infantile transmission of
Hepatitis B virus and are receiving some form of preventative treatment, like combined immunization. Caesarean
and bottle feeding are very common, often primarily to prevent transmission. Relatively few intrauterine infections
were identified in this sample, but many infants did not appear to seroconvert after vaccination.
Background
Hepatitis B virus infection is a serious public health pro-
blem. China has a high incidence of HBV infection, with
a 10% HBsAg positive rate in the general population.
There are more than 130 million chronic carriers of
HBV in China, 30% ~50% of which can be attributed to
maternal-infantile transmission[1]. Intrauterine infection
is the main contributor to maternal-infantile transmis-
sion of HBV. The intrauterine infection rate of HBsAg
-positive pregnant women is 5%~40.1% [2,3]. The exist-
ing combined immunization program, whereby high-risk
newborns receive Hepatitis B immune globulin (HBIG)
and hepatitis B vaccine, can effectively decrease mother-
to-child transmission of HBV during delivery and post-
partum, but the immune failure rate is still high, at 20%
~30%[4].
Using HBIG before childbirth[5] has been shown to be
effective in preventing intrauterine HBV infection, but
the efficacy of any specific program of immunization is
as yet inconclusive. There are very few retrospective stu-
dies on the implementation status and outcomes of
combined immunization programs since they were first
put into practice. In the present study, we retrieved all
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pregnant women and their infants from Jan 1st, 2004
through Dec.31th, 2006 in the city of Wuhan. Combined
with a designed questionnaire, we investigated the
immunization program that pregnant women received
to prevent maternal-infantile transmission of hepatitis B
and also evaluated the status of HBV infection in the
children after combined immunization.
Methods
Subjects
The HBsAg-positive pregnant women and their children
were selected as study subjects from among those who
had accepted prenatal care in the district-level Maternal
and Child Health Hospitals of Wuhan City, between Jan
1st, 2004 to Dec.31th, 2006. Of these, 158 cases were
brought into the study. Based on a hepatitis laboratory
tests, they were divided into two groups: the HBsAg+
HBeAg- group (only HBsAg-positive) and the HBsAg +
HBeAg+ group (HBsAg-positive and HBeAg-positive).
Those who accepted combined immunization and had
umbilical cord blood test results and the vein test results
after the full vaccination were selected for interview, and
the data were used to evaluate the status of their chil-
dren’s HBV infection after combined immunization.
IRB Approval/Informed consent
The study protocol will be reviewed and approved by
the Institutional Review Board of Tongji Medical Col-
lege, Huazhong University of Science & Technology,
2007(02). Data files and completed questionnaires are
kept under lock and key to ensure confidentiality of
respondents.
Informed consent was obtained from the HBsAg-posi-
tive pregnant women and their children.
Data collection
Adopting the retrospective method, correlative informa-
tion was retrieved from maternal prenatal health care
manuals of the HBsAg-positive pregnant women. This
included factors such as check-ups during early preg-
nancy, treatments to prevent maternal-infantile trans-
mission of HBV, method of delivery and feeding etc.
Trained investigators conducted face-to-face or tele-
phone interviews with the women based on a voluntary
and confidential principle using uniform questionnaires.
The content of the questionnaires included the profiles
and test results of HBV, while also determining the
immunization and HBIG treatment before and after
delivery, delivery situation and feeding patterns etc.
Questionnaires were checked after being collected, and
the entry-related information was analyzed by being
contrasted with recorded information from manuals.
Diagnostic Criteria
Diagnostic criteria for pregnant women infected with
HBV were in accordance with the diagnosis criteria of
the National Conference on Viral Hepatitis in October
2000 in Xi’an, China [6]. The diagnostic criterion for
intrauterine infection of newborns was HBV-DNA >1.0e
+003 in umbilical cord blood test results (PCR) during
delivery. The diagnostic criterion for chronic HBV infec-
tion of children was HBsAg-positive serum for six
months or more[7,8].
Combined Immunization consisted of injection of
HBsAg positive pregnant women with HBIG during
pregnancy, and their children were later given HBIG
and Hepatitis B vaccine.
Statistical analysis
EpiData 3.02 was used to establish the database. The
data were converted into an SAS database after being
checked by being input twice, and then analyzed statisti-
cally with SAS version 8.1 software. Descriptive analysis
(the calculation of average or frequency, proportion or
rate) was conducted. Single-factor analysis: (c
2 test or t
test) was used to compare the difference of qualitative
data or quantitative data, respectively.
Results
HBsAg positive description
A total of 158 cases were HBsAg positive in the random
sample (2026 pregnant women were enrolled), corre-
sponding to a HBV positive rate of 7.8 percent. Among
the 158 cases investigated, 127 cases (80.4%) had only
HBsAg-positive (HBsAg+ HBeAg- group) and 31 cases
( 1 9 . 6 % )h a dt h ec o m b i n e dH B s A ga n dH B e A g - p o s i t i v e
(double - positive group). The statistical analysis showed
no significant differences in age, occupation, education
level, income, or other general socio-economic status
between the HBsAg+ HBeAg- group (only HBsAg-posi-
tive) and HBsAg + HBeAg+ group (HBsAg-positive and
HBeAg-positive), (P >0 . 0 5 ) ,i n d i c a t i n gt h a tt h et w o
groups were comparable.
Immunization program
Among the 158 cases of HBsAg positive pregnant
women, 143 (90.5%) cases received HBIG, and 86.0%
of their children were given HBIG and Hepatitis B vac-
cine. Among the 158 women, 82.3% accepted cesarean
section, of which 28.5% were aimed at preventing HBV
infection. The rate of bottle feeding was 51.9%, and
89.0% of bottle feeding cases were for the purpose of
preventing HBV infection. In contrast, in HBsAg nega-
tive pregnant women (1868/2026), the cesarean section
ratio was 73.47%, and bottle feeding ratio was 41.80%.
Both of these were significantly lower than the
Guo et al. BMC Infectious Diseases 2010, 10:26
http://www.biomedcentral.com/1471-2334/10/26
Page 2 of 5rates of HBsAg positive pregnant women (c
2 = 5.9250,
P = 0.0149; c
2 =6 . 0 6 4 7 ,P = 0.0138).
There was no significant difference in the percentage
of women who received HBIG during pregnancy
between the HBsAg+ HBeAg- group and the HBsAg +
HBeAg+ group (Table 1). However, the caesarean sec-
tion rate of the HBsAg + HBeAg+ group was signifi-
cantly higher than the HBsAg+ HBeAg- group (P <
0.05). More double-positive than single-positive women
opted for bottle feeding (P < 0.05).
HBV infection of children
To determine the HBV status of children after com-
bined immunization, 75 cases were chosen from the
investigated HBsAg-positive pregnant women. Umbilical
cord blood and vein blood from these women and their
children were tested for HBV serological markers by lab
tests after full vaccination. Of these 75 cases, 54 were
from HBsAg+ HBeAg- group and 21 were from HBsAg
+H B e A g +g r o u p .I nt o t a l ,5c a s e sw e r eH B s A g - p o s i t i v e
as determined by umbilical cord blood test (1 from
HBsAg+ HBeAg- group, and 4 from HBsAg + HBeAg+
group). The overall intrauterine infection rate was 6.7%.
A total of 20 out of 75 cases were HBsAb positive, for a
positive rate of 26.7%.
Intrauterine infection rate of the HBsAg + HBeAg+
group (19.1%) was significantly higher than that of the
HBsAg+ HBeAg- group (1.9%), emendation c
2 = 4.6875,
P = 0.0304 (Table 2). In all, 3 cases that were HBsAg-
positive at birth turned negative after the full vaccina-
tion. Their mothers all were HBsAg and HBeAg posi-
tive. The rate of chronic HBV infection in children was
4.0%.
Discussion
The HBV carrying rate of pregnant women in Wuhan
has reportedly decreased in recent years[9]. The present
survey showed that from 2004 to 2006, the HBV carry-
ing rate was 7.8% for this region. This rate was not only
higher than that of developed countries, such
as European countries and the United States[10], but it
was also higher than that of many developing countries
[11,12]. This might be attributed, at least in part, to the
increase in HBV screening.
Maternal-infantile transmission is an important trans-
mission route for HBV; thus, strategies aimed at inter-
rupting this pathway would largely reduce the number
of new infections and would mitigate the suffering
imposed by the disease on the families, society, and indi-
viduals. In the current study, maternal-infantile trans-
mission was low with combined immunization, in which
the pregnant women receive HBIG injection during
pregnancy and their newborns get HBIG and Hepatitis
Table 1 Comparison of intervention measures between
the HBsAg+ HBeAg- group and HBsAg + HBeAg + group
Single-
positive
group (127)
Double-
positive
group (31)
Interruption
measures
n (%) n (%) c
2 P
Pregnancy HBIG
Injected
0.9726 0.3240
yes 113 (89.0) 30 (96.8)
no 14 (11.0) 1 (3.2)
Infant
immunization
1.2889 0.2563
Hepatitis B
vaccine
23 (18.1) 3 (9.7)
Hepatitis B
vaccine & HBIG
104 (81.9) 28 (90.3)
Combined
immunization
3.4802 0.0621
yes 95 (74.8) 28 (90.3)
no 32 (25.2) 3 (9.7)
Cesarean section 1.7115 0.1908
yes 102(80.3) 28(90.3)
no 25(19.7) 3(9.7)
Cesarean section
due to HBV
infection
18.2321 <0.0001
yes 20(19.6) 17(60.7)
no 82(80.4) 11(39.3)
Bottle feeding 26.7994 <0.0001
yes 53(41.7) 29(93.6)
no 74(58.3) 2(5.4)
Bottle feeding due
to HBV infection
3.9302 0.0474
yes 44(83.0) 29(100.0)
no 9(17.0) 0(0.0)
Table 2 Comparison of the HBV infection of children
between the HBsAg+ HBeAg- group and HBsAg + HBeAg+
group
Single-positive
group (127)
Double-
positive group
(31)
Infants Outcome n (%) n (%) c
2 P
Intrauterine
infection
4.6875 0.0304
yes 1(1.9) 4(19.1)
no 53(98.1) 17(80.9)
HBsAb positive 0.0541 0.8161
yes 14(25.9) 6(28.6)
no 40(74.1) 15(71.4)
HBV serological
markers full-
negative
3.5465 0.0597
yes 39(62.2) 11(52.3)
no 13(37.8) 10(47.7)
(HBV serological markers include the five items in table 1.)
Guo et al. BMC Infectious Diseases 2010, 10:26
http://www.biomedcentral.com/1471-2334/10/26
Page 3 of 5B vaccine after birth. This is in agreement with another
study, which suggested that up to 95% of maternal-
infantile transmission can be blocked by using mother-
and-baby combined immunization [13]. In our survey,
86% of the HBsAg-positive pregnant women received
HBIG before delivery, and their children were given
HBIG and Hepatitis B vaccine. The percentage of
chronic HBV infection in infants with the combined
immunization program was 4.0%, which was much
lower than those without vaccination (80%~95%)[14],
and also lower than those whose mothers had not
received HBIG (10%~15%)[15]. It is possible that a
HBsAg-positive reaction could change to negative in
children with combined immunization[16]. Despite this,
most children still lack HBsAb and are extremely sus-
ceptible to HBV infection. The reason could be two pos-
sibilities. One was insufficient or inefficient vaccination,
the other was the times of producing antibodies differ-
ing in diverse people, which leads to different outcomes
after the full-course vaccination. If children have no
HBsAb after full vaccination, they will be advised to be
revaccinated for HBV.
Mothers with positive HBeAg are at high risk for
i n t r a u t e r i n et r a n s m i s s i o n .T h e r e f o r e ,w o m e nw h oa r e
positive for HBeAg should be taken into special consid-
eration to prevent maternal-infantile transmission of
HBV. When a mother is HBV positive, a caesarean sec-
tion may be done to protect the baby from direct con-
tact with her blood and other bodily fluids. This survey
has shown that more than 80% of pregnant women with
positive HBsAg opted for cesarean section. Some studies
suggest that cesarean section could reduce the likelihood
of HBV infections in the infants [18,19], whereas other
researchers found no difference in maternal-infantile
transmission of HBV between women with cesarean sec-
tion and natural birth. This is an important considera-
tion, as cesarean section will increase medical costs,
prolong length of stay in hospital, and can add addi-
tional complications due to operation syndrome.
More than half of the investigated mothers also opted
for bottle feeding. As seen with cesarean section, dou-
ble- positive pregnant women were more worried about
the risk of transmission of HBV via breast milk, which
is still controversial [20,21].
Although recent studies have shown the effectiveness
of a combined immunization program in prevention of
vertical HBV transmission and the benefits of active and
passive immunization of infants have been recognized,
the effects of injecting HBIG before delivery are still
controversial [22,23]. At present, almost all HBsAg-posi-
tive pregnant women and even HBsAg-positive, HBeAb-
positive and HBcAb-positive women, are not recom-
mended for treatment with HBIG during pregnancy at
most hospitals in Wuhan City. Thus, the increase in
intrauterine infection and chronic infection is still a con-
cern. According to the principles of evidence-based
medicine, a well-designed and forward-looking study is
needed, with large samples in multi-center organiza-
tions. We can then make a comprehensive assessment
of the effects of giving HBIG to pregnant women for
prevention of maternal-infantile transmission of HBV.
Conclusion
M o s tH B Vp o s i t i v ep r e g n a n tw o m e nh a v eag r o w i n g
awareness of maternal-infantile transmission of Hepatitis
B virus and are receiving some form of preventative
treatment. For example, their children are given HBIG
and Hepatitis B vaccine and/or HBsAg positive pregnant
women are injected with 3-5 doses of HBIG during
pregnancy. Caesarean section and bottle feeding are very
common, often performed primarily to prevent HBV
transmission. Relatively few intrauterine infections were
identified in this sample, but many infants did not
appear to seroconvert after vaccination.
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